- Home
- SOUNW vs FBIOP Comparison
SOUNW vs FBIOP Comparison
Compare SOUNW & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOUNW
- FBIOP
- Stock Information
- Founded
- SOUNW N/A
- FBIOP N/A
- Country
- SOUNW United States
- FBIOP United States
- Employees
- SOUNW 260
- FBIOP 186
- Industry
- SOUNW EDP Services
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- SOUNW Technology
- FBIOP Health Care
- Exchange
- SOUNW Nasdaq
- FBIOP Nasdaq
- Market Cap
- SOUNW N/A
- FBIOP N/A
- IPO Year
- SOUNW 2021
- FBIOP N/A
- Fundamental
- Price
- SOUNW $9.00
- FBIOP $6.98
- Analyst Decision
- SOUNW
- FBIOP
- Analyst Count
- SOUNW 0
- FBIOP 0
- Target Price
- SOUNW N/A
- FBIOP N/A
- AVG Volume (30 Days)
- SOUNW N/A
- FBIOP N/A
- Earning Date
- SOUNW N/A
- FBIOP N/A
- Dividend Yield
- SOUNW N/A
- FBIOP N/A
- EPS Growth
- SOUNW N/A
- FBIOP N/A
- EPS
- SOUNW N/A
- FBIOP N/A
- Revenue
- SOUNW N/A
- FBIOP N/A
- Revenue This Year
- SOUNW N/A
- FBIOP N/A
- Revenue Next Year
- SOUNW N/A
- FBIOP N/A
- P/E Ratio
- SOUNW N/A
- FBIOP N/A
- Revenue Growth
- SOUNW N/A
- FBIOP N/A
- 52 Week Low
- SOUNW N/A
- FBIOP N/A
- 52 Week High
- SOUNW N/A
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- SOUNW N/A
- FBIOP 56.58
- Support Level
- SOUNW N/A
- FBIOP $6.75
- Resistance Level
- SOUNW N/A
- FBIOP $6.97
- Average True Range (ATR)
- SOUNW 0.00
- FBIOP 0.38
- MACD
- SOUNW 0.00
- FBIOP -0.02
- Stochastic Oscillator
- SOUNW 0.00
- FBIOP 70.37
About SOUNW SoundHound AI Inc. Warrant
SoundHound AI Inc is an innovator of conversational intelligence, offering an independent Voice AI platform that enables businesses across industries to deliver high-quality conversational experiences to customers.
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.